Autism spectrum disorder is a lifelong developmental difference that affects social communication, behaviour and how a person experiences the world. Some researchers have explored whether stem cells, especially from umbilical cord blood, could calm inflammation or change brain connectivity, but autism is not a disease caused by missing or damaged cells that stem cells could replace.
AT A GLANCE · AUTISM
| Evidence level | Unproven / not recommended outside trials |
|---|---|
| Approved stem cell treatment? | No stem cell or cord blood product is approved for autism by the US FDA, the European EMA, or regulators in Japan or Korea. |
| Typical private price | $10,000 – $40,000 (indicative) |
| Recruiting trials | 9 listed on ClinicalTrials.gov (4 October 2026) |
| Last reviewed | October 2026 |
Does stem cell therapy work for autism?
The best-known research comes from Duke University. A small open-label safety study in 2017 gave 25 children their own banked cord blood and reported parent-rated improvements, but it had no control group, so those changes could not be separated from normal development or expectation effects. Duke then ran a larger randomised, double-blind, placebo-controlled trial in 180 children aged 2 to 7, published in 2020 in the Journal of Pediatrics. A single cord blood infusion, either from the child’s own cord or from a donor, did not improve social skills or reduce autism symptoms compared with placebo, missing its primary and secondary goals.
A possible small signal in a subgroup of children without intellectual disability was found only after the fact and experts called it at best suggestive. Duke stopped offering autism in its paid expanded-access programme at the end of 2022 (families were told in early 2023), saying its 2020 trial did not clearly show benefit. Other small studies using cord-tissue or other cell types are mostly uncontrolled, and there is no high-quality evidence that any stem cell product improves autism.
Is any stem cell treatment approved for autism?
No stem cell or cord blood product is approved for autism by the US FDA, the European EMA, or regulators in Japan or Korea. Cord blood is FDA-approved only for certain blood and immune disorders, not for autism. Any autism stem cell treatment outside a registered clinical trial is unapproved.
What private clinics offer — and how it compares
Private clinics, often in Panama, Mexico and other countries, sell packages of umbilical cord-derived cells by IV drip or spinal injection and share parent testimonials of better speech, eye contact or behaviour. These claims rely on anecdotes and uncontrolled reports, whereas the largest placebo-controlled trial to date found no benefit.
Proven treatments to discuss first
Before paying for an experimental option, make sure you have explored the established treatments for autism with your doctor:
- Early developmental and behavioural intervention programmes (including naturalistic and parent-mediated approaches)
- Speech and language therapy and communication supports (including AAC devices)
- Occupational therapy for sensory, motor and daily living skills
- Educational support plans and school-based services
- Medical care for co-occurring issues such as sleep problems, epilepsy, anxiety, ADHD or gut symptoms
- Medication for severe irritability or aggression when recommended by a specialist
How much does stem cell therapy for autism cost?
Private clinics typically quote $10,000 to $40,000. Reporting from autism news outlet Spectrum (2019) found clinics in Panama and Mexico charging about $15,000 per treatment, with many families paying for several rounds; Duke’s own paid expanded-access programme charged roughly $10,000 to $15,000 before it closed in 2023. Totals can reach tens of thousands of dollars plus travel. Compare prices by country in our cost guide and location guides, and check insurance coverage.
Risks and side effects
- Sedation or general anaesthesia for spinal (intrathecal) injections in children
- Infection, meningitis or contamination from poorly regulated cell products
- Allergic or immune reactions to donor cells, including fever and infusion reactions
- Large out-of-pocket costs and repeated ‘top-up’ treatments abroad with no proven benefit
- Time and money diverted from proven therapies during key developmental years
Recruiting clinical trials for autism
On 4 October 2026, ClinicalTrials.gov listed 9 recruiting or soon-to-recruit stem cell studies for this condition, 3 with sites in the United States. Here are up to eight, latest-stage first:
| Study | Phase | Locations | Status |
|---|---|---|---|
| Prospective Clinical Study on Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes for the Treatment of Childhood Autism | Phase 1/Phase 2 | China | Recruiting |
| Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Autism | Phase 1 | Antigua and Barbuda, Greece | Recruiting |
| Allogeneic Wharton Jelly Mesenchymal Stromal Cell (WJMSC) for Treatment of Autism | Phase 1 | Jordan | Recruiting |
| GAIP ASD Research Study | Phase 1 | United States | Recruiting |
| Adia Med of Winter Park LLC Autism Spectrum Disorder Research Study | Phase 1 | United States | Recruiting |
| Baker Gordon Syndrome Natural History Study | N/A | United States | Recruiting |
| A Study of Mesenchymal Stem Cell in the Treatment of Autism Spectrum Disorder | Phase 1 | — | Not Yet Recruiting |
| Umbilical Cord Blood Therapy in a Child With Eosinophilic Duodenitis and Autism Spectrum Disorder: a Case Study | N/A | — | Not Yet Recruiting |
See all matching studies on ClinicalTrials.gov. A listing is not an endorsement: registration does not mean a study is safe or effective, and genuine trials rarely charge you for the experimental treatment. Ask the study team about costs, placebo groups and follow-up before you enrol. See our clinical trials hub.
Questions to ask before you agree to treatment
- How does your treatment differ from the Duke cord blood trial, which found no benefit over placebo?
- Is this a registered clinical trial with a placebo group and independent ethics approval?
- Will my child need sedation or a spinal injection, and who manages complications after we return home?
- Exactly what cells are used, where do they come from, and how are they tested for infection and quality?
Before You Pay: The Stem Cell Clinic Checklist
- 20 questions every legitimate clinic should answer in writing
- A red-flag scorecard to spot unregulated marketing
- Realistic 2026 cost ranges: US, Mexico, Panama & Europe
- How to find a registered clinical trial
Red flags to watch for
- Promises of improved speech, eye contact or ‘recovery’ from autism
- Recommending repeat infusions or spinal injections for a young child without a registered trial protocol
- Asking families to pay upfront for a so-called study or trial
Stem cell therapy for autism: FAQs
Does stem cell therapy work for autism?
There is no reliable evidence that it does. The largest randomised, placebo-controlled trial, run by Duke University with 180 children and published in 2020, found that a cord blood infusion did not improve social skills or autism symptoms compared with placebo. Positive stories mostly come from uncontrolled studies and testimonials.
How much does stem cell therapy for autism cost?
Reported prices at overseas clinics are around $15,000 per treatment, and families are often encouraged to return for more rounds. With travel, totals can run to tens of thousands of dollars. These costs are almost never covered by insurance.
Is stem cell therapy FDA approved for autism?
No. The FDA has not approved any stem cell or cord blood product for autism. Cord blood is approved only for certain blood and immune system disorders.
What happened with the Duke autism cord blood study?
After an early open-label study suggested improvements, Duke ran a larger controlled trial that did not find a benefit. Duke stopped offering autism in its paid expanded-access programme at the end of 2022, saying its 2020 trial did not clearly show benefit.
Is stem cell therapy for autism covered by insurance?
No. Because it is unproven and unapproved for autism, insurers do not cover it. Proven supports such as speech therapy, occupational therapy and developmental programmes are more likely to be covered or funded through education services.
Related guides
- Stem cell therapy for spinal cord injury
- Stem cell therapy for multiple sclerosis
- Stem cell therapy for ALS
- Stem cell therapy for stroke
- All conditions · Types of stem cell treatment · Clinical trials hub
Sources
- Study finds little evidence to back cord-blood therapy for autism (The Transmitter / Spectrum)
- Duke Autism Center trial: no benefit of cord blood for autism (The Niche)
- False hope for autism in the stem-cell underground (The Transmitter / Spectrum)
- Duke has quietly discontinued a costly, unproven autism treatment (Vice)
- Duke Center for Autism: IMPACT study details
- FDA: Important patient and consumer information about regenerative medicine therapies
Last reviewed October 2026. For general information only — not medical advice. We do not endorse any clinic or product. Always consult a qualified, licensed healthcare professional. See our medical disclaimer and editorial policy.